Soler J J, Morales P, Benlloch E, Cordero P J, Macián V
Servicio de Neumología, Hospital Universitario La Fe, Valencia.
Arch Bronconeumol. 1997 Apr;33(4):172-8. doi: 10.1016/s0300-2896(15)30626-8.
We studied 20 patients with obstructive sleep apnea syndrome (OSAS) prospectively, before and after administering continuous positive airway pressure through a nasal mask (CPAPn) at night for 10 months, with the aim of determining the effects of ventilatory pattern of long-term treatment with CPAPn in OSAS patients. The following data were collected for all patients: anthropometric variables, lung function test results, arterial gasometric readings at rest, oxygen alveolar-arterial differential [Dif(A-a)O2)], central respiratory function variables at rest and during hypercapnic stimulus. Mean duration (range) of treatment with CPAPn was 12.5 (10-18) months. We observed a significant increase in PaO2 (p = 0.01) and a decrease in PaCO2 (p = 0.02) with slight variations in body weight and no changes in lung mechanics or in Dif(A-a)O2. The ventilatory pattern at rest showed an increased in VE and in respiratory frequency (p = 0.0003 and p = 0.033, respectively) with non significant changes in VT. The VT/Ti ratio increased (p = 0.015) and P0.1 decreased slightly (p = 0.025). We found no significant changes in the CO2 response slopes of VE or P0.1. In conclusion, CPAPn improves hypoxemia and hypercapnia in OSAS patients, above all by increasing baseline basal ventilation. The exact mechanisms implicated are poorly understood, but our data suggest a certain direct or indirect effect on respiratory muscles, reducing muscle fatigue, thus favoring greater availability during sleep.
我们前瞻性地研究了20例阻塞性睡眠呼吸暂停综合征(OSAS)患者,在夜间通过鼻罩持续气道正压通气(CPAPn)治疗10个月前后,目的是确定长期CPAPn治疗通气模式对OSAS患者的影响。收集了所有患者的以下数据:人体测量变量、肺功能测试结果、静息时动脉血气读数、氧肺泡-动脉差值[Dif(A-a)O2]、静息时和高碳酸血症刺激期间的中枢呼吸功能变量。CPAPn治疗的平均持续时间(范围)为12.5(10 - 18)个月。我们观察到PaO2显著升高(p = 0.01),PaCO2降低(p = 0.02),体重略有变化,肺力学或Dif(A-a)O2无变化。静息时的通气模式显示VE和呼吸频率增加(分别为p = 0.0003和p = 0.033),VT无显著变化。VT/Ti比值增加(p = 0.015),P0.1略有降低(p = 0.025)。我们发现VE或P0.1的CO2反应斜率无显著变化。总之,CPAPn改善了OSAS患者的低氧血症和高碳酸血症,主要是通过增加基线基础通气。其中的确切机制尚不清楚,但我们的数据表明对呼吸肌有一定的直接或间接影响,减少肌肉疲劳,从而有利于睡眠期间有更大的可用性。